| Ann Y Lagerlund, MD | |
|
945 N 12th St, Milwaukee, WI 53233-1305 | |
| (414) 219-5800 | |
| Not Available |
| Full Name | Ann Y Lagerlund |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 17 Years |
| Location | 945 N 12th St, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497965172 | NPI | - | NPPES |
| 100031082 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 60193 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora St Lukes Medical Center | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
Skinvisible, Inc. the developers of Invisicare, a polymer delivery system that enhances topically applied products, has been granted a comprehensive patent in Australia.
A disproportionate number of people hospitalized in Canada with traumatic brain injuries are 65 years or older, a new study from St. Michael's Hospital has found.
Isis Pharmaceuticals, Inc. announced today that it has earned a $6 million milestone payment from Bristol-Myers Squibb Company related to the acceptance of initial regulatory filings to begin Phase 1 clinical studies for BMS-PCSK9Rx. BMS-PCSK9Rx is an antisense drug that arose out of the ongoing collaboration between Bristol-Myers Squibb and Isis to identify antisense drugs targeting PCSK9 to lower low-density lipoprotein (LDL) cholesterol.
K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced that with the recent addition of multiple breakthrough technologies, K2M offers a market leading comprehensive product portfolio to be exhibited at the North American Spine Society (NASS) Annual Meeting.
The Massachusetts Senate Tuesday approved a bill that would make wealthy hospitals pay $100 million in a one-time contribution to help small businesses ease insurance premiums. "The bill would let businesses with 50 or fewer workers form cooperatives to purchase insurance at a lower cost. Another provision presses insurers to spend at least 90 percent of premium dollars on care and 10 percent or less on administrative costs.
› Verified 6 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
Skinvisible, Inc. the developers of Invisicare, a polymer delivery system that enhances topically applied products, has been granted a comprehensive patent in Australia.
A disproportionate number of people hospitalized in Canada with traumatic brain injuries are 65 years or older, a new study from St. Michael's Hospital has found.
Isis Pharmaceuticals, Inc. announced today that it has earned a $6 million milestone payment from Bristol-Myers Squibb Company related to the acceptance of initial regulatory filings to begin Phase 1 clinical studies for BMS-PCSK9Rx. BMS-PCSK9Rx is an antisense drug that arose out of the ongoing collaboration between Bristol-Myers Squibb and Isis to identify antisense drugs targeting PCSK9 to lower low-density lipoprotein (LDL) cholesterol.
K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced that with the recent addition of multiple breakthrough technologies, K2M offers a market leading comprehensive product portfolio to be exhibited at the North American Spine Society (NASS) Annual Meeting.
The Massachusetts Senate Tuesday approved a bill that would make wealthy hospitals pay $100 million in a one-time contribution to help small businesses ease insurance premiums. "The bill would let businesses with 50 or fewer workers form cooperatives to purchase insurance at a lower cost. Another provision presses insurers to spend at least 90 percent of premium dollars on care and 10 percent or less on administrative costs.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ann Y Lagerlund, MD Po Box 735044, Chicago, IL 60673-5044 Ph: () - | Ann Y Lagerlund, MD 945 N 12th St, Milwaukee, WI 53233-1305 Ph: (414) 219-5800 |
News Archive
Skinvisible, Inc. the developers of Invisicare, a polymer delivery system that enhances topically applied products, has been granted a comprehensive patent in Australia.
A disproportionate number of people hospitalized in Canada with traumatic brain injuries are 65 years or older, a new study from St. Michael's Hospital has found.
Isis Pharmaceuticals, Inc. announced today that it has earned a $6 million milestone payment from Bristol-Myers Squibb Company related to the acceptance of initial regulatory filings to begin Phase 1 clinical studies for BMS-PCSK9Rx. BMS-PCSK9Rx is an antisense drug that arose out of the ongoing collaboration between Bristol-Myers Squibb and Isis to identify antisense drugs targeting PCSK9 to lower low-density lipoprotein (LDL) cholesterol.
K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced that with the recent addition of multiple breakthrough technologies, K2M offers a market leading comprehensive product portfolio to be exhibited at the North American Spine Society (NASS) Annual Meeting.
The Massachusetts Senate Tuesday approved a bill that would make wealthy hospitals pay $100 million in a one-time contribution to help small businesses ease insurance premiums. "The bill would let businesses with 50 or fewer workers form cooperatives to purchase insurance at a lower cost. Another provision presses insurers to spend at least 90 percent of premium dollars on care and 10 percent or less on administrative costs.
› Verified 6 days ago
Dr. Colleen Ann Crowe, M.D., M.P.H. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-6469 | |
Natalia Rumas, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2323 N Lake Dr, Milwaukee, WI 53211 Phone: 414-290-6720 Fax: 414-290-6755 | |
Adam C Ankrum, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 111 E Wisconsin Ave, Suite 2000, Milwaukee, WI 53202 Phone: 414-290-6720 Fax: 414-290-6755 | |
Andrea Michelle Kraus, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3237 S 16th St Ste 100, Milwaukee, WI 53215 Phone: 414-647-5203 Fax: 414-858-2236 | |
Lisa Hubbard, CFNP Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 5000 W Chambers St, Milwaukee, WI 53210 Phone: 414-447-2000 Fax: 414-874-4393 | |
Mr. Brad A. Johnson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 W Oklahoma Ave, Milwaukee, WI 53215 Phone: 414-649-6000 | |
Mckenna Jean Knych, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-6450 Fax: 414-805-6464 |